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A high prevalence of abnormal nutrition parameters found in predialysis endstage kidney disease: is it a result of uremia or poor eating habits?
Abstract
Objective To describe the baseline nutritional characteristics of a cohort of end-stage kidney disease
(ESKD) patients attending a pre-dialysis clinic. Setting Outpatient clinic of a metropolitan tertiary teaching
hospital in Sydney, Australia. Subjects All ESKD patients attending the multidisciplinary pre-dialysis
assessment clinic between April 2002 and March 2008. Methods Retrospective analysis of data extracted
from the routine initial nutrition assessment records. These included anthropometric and biochemical
measures, Subjective Global Assessment, appetite score, presence of symptoms, dietary energy, protein,
and other macro- and micronutrient intakes. Results Of the 210 patients assessed, 60.5% were male;
mean age was 65.7 ± 13.6 years with a mean glomerular filtration rate of 17.3 ± 6.5 mL/min/1.73 m2;
17.1% and 62.4% were underweight (body mass index /m2) and overweight or obese (BMI ≥26 kg/m2),
respectively; 40.5% were rated as malnourished (Subjective Global Assessment scores B and C) with
19.0% overweight/obese and malnourished. Energy and protein intakes correlated positively with
glomerular filtration rate, with r = 0.17, P = .01, and r = 0.29, P < .0001 respectively. Mean energy and
protein intakes were 23.7 ± 6.7 kcal/kg IBW/day and 1.18 ± 0.42 g/kg IBW/day, with 62.6% and 13.1% not
meeting the recommended intake, respectively. The positive predictive values (95%CI) of self-rated
appetite score for energy and protein were 0.41 (0.36-0.45) and 0.92 (0.88-0.95), respectively, indicating
subjective rating of a good appetite was associated with adequate protein but not energy intake. Fifty-one
percent of the patients experienced the symptoms, whereas 17.5% of the patients self-imposed a dietary
regimen inappropriately due to beliefs on dietary needs in ESKD. Suboptimal nutrient intakes were
observed, including vitamin B2 (41.2%), vitamin E (61.8%), folate (67.6.2%), vitamin D (100.0%), and zinc
(64.2%). Conclusion Patients presented to the pre-dialysis assessment clinic with abnormal nutrition
parameters associated with decreased renal function, symptoms burden, and poor dietary intake. This
clinic may provide an opportunity to optimize the nutritional status of ESKD patients in the pre-dialysis
period.
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Abstract:
Objective: To describe the baseline nutritional characteristics of a cohort of end stage kidney
disease (ESKD) patients attending a pre-dialysis clinic.
Setting: Outpatient clinic of a metropolitan tertiary teaching hospital in Sydney, Australia.
Subjects: All ESKD patients attending the multidisciplinary pre-dialysis assessment clinic
between April 2002 and March 2008.
Methods: Retrospective analysis of data extracted from the routine initial nutrition
assessment records. These included anthropometric and biochemical measures, subjective
global assessment (SGA), appetite score, presence of symptoms, dietary energy, protein,
other macro- and micronutrient intakes.
Results: Of the 210 patients assessed, 60.5% were male; mean age was 65.7±13.6 years with
a mean glomerular filtration rate (GFR) of 17.3±6.5 mL/min/1.73m2. 17.1% and 62.4% were
underweight (BMI <23 kg/m2) and overweight or obese (BMI ≥26 kg/m2) respectively.
40.5% were rated as malnourished (SGA score B and C) with 19.0% overweight/obese and
malnourished. Energy and protein intakes correlated positively with GFR, being r =0.17, P
=0.01 and r =0.29, P <0.0001 respectively. Mean energy and protein intakes were 23.7±6.7
kcal/kg IBW/d and 1.18±0.42 g/kg IBW/d, with 62.6% and 13.1% not meeting the
recommended intake respectively. The positive predictive values (95%CI) of self-rated
appetite score for energy and protein were 0.41 (0.36-0.45) and 0.92 (0.88-0.95) respectively
indicating subjective rating of a good appetite was associated with adequate protein but not
energy intake. 51.0% of patients experienced symptoms, while 17.5% of patients selfimposed a dietary regimen inappropriately due to beliefs on dietary needs in ESKD. Suboptimal nutrient intakes were observed including vitamin B2 (41.2%), vitamin E (61.8%),
folate (67.6.2%), vitamin D (100.0%) and zinc (64.2%).
10

Conclusion: Patients presented to the pre-dialysis assessment clinic with abnormal nutrition
parameters associated with decreased renal function, symptoms burden, and poor dietary
intake. This clinic may provide an opportunity to optimise nutritional status of ESKD patients
in the pre-dialysis period.

11

Introduction
Poor nutritional status and presence of protein energy wasting (PEW) at the start of dialysis
are associated with morbidity, mortality and hospitalisation1-6. Thus, timely nutrition
intervention is important in end stage kidney disease (ESKD) well before dialysis is required.
Indeed, nutritional status deteriorates during the course of decline of renal function,7, 8 and the
presence of nutrition abnormalities is known to associate with adverse outcomes, including
accelerated atherosclerosis,9 mortality and hospitalisation.10 Cross-sectional7,
longitudinal8,

15

11-14

and

studies have established that spontaneous intakes of protein and energy

decline as GFR falls. Furthermore, poor appetite, commonly found in dialysis-dependent
ESKD patients, has been associated with mortality, morbidity and hospitalisation.16, 17 On the
other hand, over-nutrition, such as the presence of obesity at the start of dialysis, is associated
with high mortality risk.5 However, other researchers found the protective effect of obesity in
patients with ESKD, which is known as the “obesity paradox”.18 All these highlight the
complex and heterogeneous nutritional abnormalities of patients with ESKD before and after
starting dialysis. Historically, nutritional intake studies in pre-dialysis ESKD patients have
been mainly focused on energy and protein intake. Other nutrients, food patterns or intake of
specific foods such as fruit and vegetables have received relatively little attention. In order to
establish sound clinical practice, it is necessary to gain a broader insight into nutritional
parameters, including dietary intake of energy, protein and other nutrients, information on
food patterns, the presence of symptoms and clinical indicators of the nutritional status of
these patients. Therefore, our study was differing to previous studies and encompassed many
of these parameters in one study. It is also worth noting the growing number of elderly
patients entering the advanced renal care program19 with additional age-related nutritional
health concerns, such as osteoporosis and sarcopenia. The aim of this study was to describe
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the baseline demographic, clinical and nutritional characteristics of a cohort of ESKD
patients who attended an outpatient pre-dialysis assessment clinic.

Methods
This retrospective study examined clinical and initial routine nutrition assessment records of
all patients attending an outpatient pre-dialysis assessment clinic established in April 2002
through March 2008. Patients referred by renal physicians to this multidisciplinary clinic
were predominantly in CKD stages 4 and 5 (GFR <30 mL/min/1.73m2) and were assessed by
the clinical nurse consultant, pharmacist, social worker and dietitian (MC). Exclusion criteria
were those patients who missed the dietitian assessment, incomplete or unreliable assessment
data, or late referral to the pre-dialysis assessment team during acute hospital admission, with
dialysis expected to start within next 1–2 months.

Demographic and clinical data:
From hospital records, data collected including age, gender, race, smoking habits and
presence of co-morbidities, e.g., coronary artery disease (CAD), diabetes mellitus (DM),
chronic lung disease (CLD) and peripheral vascular disease (PVD).

Anthropometrical and biochemical data
Anthropometric measures performed by the dietitian were height (m); oedema-free body
weight (kg); body mass index (BMI weight  height2, [kg/m2]) and weight history; mid-arm
circumference (MAC) and triceps skinfold (TSF). Mid-arm muscle circumference (MAMC)
was calculated using the following formula: MAMC (cm) = MAC (cm) – 0.314 x TSF (mm).
The clinical practice guidelines20 define a healthy range for BMI of 22–26 kg/m2; therefore
BMI ≥26 kg/m2 was treated as overweight. Prevalence of renal-specific BMI categories20, 21
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were also examined with undernourished, ideal range, overweight and obese defined as BMI
<23, 23–26, 26–30 and ≥30 kg/m2 respectively. Muscle wasting was classified as MAMC
>10% and <50th percentile of the reference standard for age and gender.21,

22

Blood results

closest to and within 2 months of the clinic were extracted from clinical notes; these included
serum-albumin (s-albumin) and serum creatinine to calculate GFR using the Cockcroft-Gault
equation.23 Approximately 50% of the blood tests were analysed in private providers instead
of the hospital-based laboratory; thus, different analytical methods used for s-albumin with
different reference ranges. Therefore, for the s-albumin levels, both actual figures plus
whether they were below or within reference ranges were recorded for analysis.
Subjective global Assessment (SGA)
The renal dietitian(s) (MC) performed the subjective global assessment (SGA),24,

25

which

categorised patients as A = well nourished, B = mild-moderately and C = severely
malnourished, based on the patient’s medical history and physical examination. The
prevalence of combined malnutrition (SGA score = B and C) and BMI (<26 kg/m2 vs. 26
kg/m2) were also examined.

Appetite, Symptoms and Intake Assessment
Patients’ subjective rating of appetite was assessed using the Appetite and Diet Assessment
Tool (ADAT) with a 5-point Likert scale:26 (1) very good, (2) good, (3) fair, (4) poor and (5)
very poor. For easy comparison, appetite scores were combined into “good appetite” (very
good and good) versus “reduced appetite” (fair, poor and very poor). The presence of other
nutrition-related symptoms were also assessed, e.g., nausea and taste aversion. A “typical
day’s dietary intake” was assessed by the dietitian using a structured diet history or diet
interview method,27-30 taking into account food frequency and weekend variations. Food
pictures and models, household metric measuring cup and spoons were used to assist serving
size estimation. The structured diet history method is considered to be a feasible method for
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the initial outpatient clinic visit compared with the 3-day food record used in other studies.12,
13

Urinary nitrogen excretion was not routinely collected in our unit, so we were not able to

measure nitrogen appearance to estimate protein intake as in previous studies.11,

15

Dietary

intake data were analysed using a computerised nutrient analyses program (FoodWorks
Professional Model 2009, Xyris, Brisbane, Australia) to estimate energy intake (EI), dietary
protein intake (DPI) and intake of other nutrients. EI and DPI intakes were expressed in kcal
and g per kg IBW (ideal body weight) per day or kcal/kg IBW/d and g/Kg IBW/d
respectively. For overweight patients, adjusted body weight (adjusted BW) was used instead
of IBW; adjusted BW = IBW + [(oedema-free BW – IBW) x 0.25].20, 31
To evaluate possible underreporting, the ratio of EI to resting energy expenditure (REE) was
calculated using the Schofield equation.32 An EI:REE ratio less than 1.27 (known as the
Goldberg cut-off value)33, 34 may indicate possible underreporting of EI; if an EI:REE <1.27
was present, other explanations of low EI were also reviewed, e.g., presence of symptoms
and physical inactivity defined as physical activity level (PAL) equal or less than 1.5.35, 36 In
the current study, PAL was rated according to patients’ description of their typical daily
physical activity including any participation in leisure or structured exercise programs.
Average daily consumptions of fruit, vegetable and fish were surveyed and compared to the
Australian Guide of Health Eating recommendations of “two fruit and five vegetables”37 and
the American Heart Association’s “Healthy diet goals”38 of at least two servings of fish per
week (equivalent to approximately 30 grams per day).

Statistical analyse
All statistical analyses were performed using the statistical software IBM© SPSS© Statistics
version 20. Continuous variables were expressed as mean ± standard deviation for normally
distributed data and comparisons between groups were performed using unpaired sample t-
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tests. Categorical variables were compared using the 2 test. Correlations between GFR and
dietary energy and protein intakes were estimated using Pearson correlation coefficients.
Analysis of variance (ANOVA) was used to compare the parameters among three to four
categories. The positive predictive values (PPV) of appetite score for adequate energy (≥25
g/kg IBW/d)21 and protein intake (≥0.75 g/kg IBW/d)20 were assessed using the two-way
contingency analysis table.39 P values <0.05 were taken as showing a statistically significant
difference. This study was approved by the ethics committee of the South Eastern Sydney
and Illawarra Area Health Service, NSW, Australia.
Results
Two hundred and twenty-seven patients attended the pre-dialysis assessment clinic during the
study period. Two hundred and ten patients were assessed by the dietitian with 206 reliable
dietary assessment records available for computerised nutrient analysis. Table 1 summarises
the demographic and clinical characteristics of these patients. Patients were predominantly in
CKD stages 4 (56.5%) and 5 (38.2%) with a mean GFR of 17.3±6.5 mL/min/1.73m2. The
main cause of ESKD was diabetic nephropathy (24.2%).
A high prevalence of nutrition abnormalities was found in this cohort. As shown in Table 2.
the prevalence of malnutrition (SGA = B and C) was 40.5% and 19.0% of patients were
overweight and malnourished. Within the malnourished group, 47.1% of patients were
overweight/obese, and within the overweight/obese group, 30.5% of patients were rated as
malnourished. Unintentional loss of body weight was not uncommon in this population and
37.3% of patient had s-albumin levels below the reference range. 28.4% of patients were
classified as muscle-wasted according to the PEW criteria.21
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Approximately 14.8% of patients reported having previous contact with dietitian(s) for
various diet interventions, but rarely (<5%) related to CKD stage 4 or 5 dietary management
with structured care and regular follow-up. Therefore, all of these dietary data were
considered as spontaneous intake. As expected, energy and protein intake correlated
significantly with GFR: r =0.17, P =0.01 (Figure 1) and r =0.29, P <0.0001 (Figure 2)
respectively. However, as shown in Table 3, energy and nutrient intake and food habits
varied vastly among individuals. Mean EI was low at 23.7±6.7 kcal/kg IBW/d with 87.9% of
patients having an EI below the recommended ~35 kcal/kg IBW/d for <60 years of age and
~30 kcal/d for >60 years of age.

20, 40

21

According to the PEW classification of no less than 25

kcal/kg IBW/d, 62.6% of patients had insufficient EI. 76.2% of patients had an EI:REE ratio
(Goldberg cut-off) <1.27 and 41.7% had an EI below REE (ratio <1.00). However, further
analysis indicated that these patients, when compared to those with an EI:REE ratio >1.27,
had significantly higher prevalence of malnutrition (45.2% vs. 26.5%, 2=5.4, P =0.02).
Furthermore, the majority of patients (88.3%) were very inactive, with a PAL of 1.5
(sedentary) or less (very sedentary or bed-/chair-ridden), and 22.8% reported a reduced
physical function under the SGA sub-category of physical function rating. The mean protein
intake was 1.18±0.42 g/kg IBW/d with 13.1% below and 61.2% above the ideal range of
0.75–1.00 g/kg IBW/d.20 4.9% of patients consumed less than the 0.6 g/kg IBW/d level
traditionally prescribed for a low protein diet.41
The 5-point Likert scale appetite score was found useful in ranking and correlated with the
incremental changes of both EI and DPI; EI was 25.4±6.0, 24.2±6.8, 22.0±6.8, 19.4±6.2 and
14.9±1.8 kcal/kg IBW/d (P =0.002) respectively (Figure 3); and the same applied for DPI of
1.32±0.36, 1.17±0.45, 1.13±0.44, 0.86±0.25 and 0.57±0.18 g/kg IBW/d (P =0.001) (Figure 4)
For the combined scores of “good” and “reduced” appetite for protein and energy intakes, the
rating showed statistical difference between the EI and DPI of 24.7±6.5 vs. 21.2±6.7 kcal/ kg

17

IBW/d (P =0.001) and 1.24±0.42 vs. 1.06±0.42g/kg IBW/d (P =0.006) respectively. The PPV
(95%CI) of appetite rating for energy and protein were 0.41 (0.36-0.45) and 0.92 (0.88-0.95)
respectively. These reflect 41% of patients rated a “good appetite” and consumed adequate
energy, while the remainder (59%) rated “good appetite” but did not consume adequate
energy. The PPV for DPI was 0.92 reflecting the appetite rating was satisfactory in
identifying adequate protein intake.
38.1% of patients reported the presence of symptoms including reduced appetite, and/or
nausea and/or taste aversion. However, with further prompting during the in-depth dietary
intake assessment by the dietitian, a total of 51.0% of patients and/or their carers disclosed
“problems” with eating of various degrees. The mean intakes of energy and protein between
the “no symptom” versus “presence of symptom” groups were 25.7±6.3 vs. 21.8±6.3 kcal/kg
IBW/d (P <0.0001) and 1.33±0.42 vs. 1.05±0.39 g/kg IBW/d (P <0.0001) respectively.
Furthermore, during the in-depth dietary intake assessment, 17.1% of patients were found to
impose inappropriate dietary regimens due to misconceptions of nutrition knowledge for
ESKD. Examples of inappropriate restriction (15.7%) included: severe reduction of total fat
and sugar intake being mistaken for good eating habits or for lipid-lowering or weight
management; limiting fruit and vegetables to control serum potassium when it was not
required; and/or severe limiting of protein foods, especially red meat, in an attempt to manage
kidney disease. Inappropriate excess food intake (1.4%) was found in diabetic patients to
avoid hypoglycaemia (“hypos”) and the use of a high protein-low carbohydrate diet for
controlling weight. The sources of confusion mainly came from advice from relatives or
friends, other health care practitioners and from misinterpreting information from the
Internet. The inappropriate intake group, when compared with the spontaneous intake group,
had significant reduced mean intake of energy and protein of 21.2±4.0 vs. 24.2±7.1 kcal/kg
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IBW/d (P =0.02) and 1.02±0.33 vs. 1.22±0.44 g/kg IBW/d (P =0.01) respectively. The “▲”
symbol shown in Figures 1 and 2 represents the inappropriate energy and protein intakes
among all patients, and the majority of self-imposed dietary restrictions had led to suboptimal
intake. Within this group of 33 patients, 54.5% of those were rated as malnourished, mainly
as a consequence of self-induced poor intake.
Regarding the other nutrient intakes (Table 3), the mean intakes of folate, vitamin D, vitamin
E, calcium, iodine, magnesium, zinc and dietary fibre were below the RDI.36 41.3% and
89.2% of patients did not consume the recommended two serves of fruit and five serves of
vegetables each day. 60.8% of patients consumed less than the recommended servings of fish
(equivalent to 30 g/day). Many of these patients reported inadequate fruit, vegetables and fish
intake as their usual food habits. However the prevalence was not available for all patients
due to the retrospective nature of the study.
Patients in later stages of CKD or lower GFR levels were generally older, had lower protein
intake, lower BMI and other anthropometric measures (Table 5). The prevalence of
malnutrition and presence of symptoms increased as GFR decreased and were high in all
groups. No statistical difference was observed across all groups for the mean EI (P
=0.18), which was suboptimal in the majority of patients.
Among the three age groups: <65, 65–75 and >75 years (Table 6), anthropometric measures
such as BMI and MAMC (% standard) were lower in the >75 year age group, but no
statistical difference was found in the TSF (% standard) among the three groups. This
reflected that older patients were more likely to be muscle-depleted, but not necessarily lower
in their fat stores. No statistical difference was observed for dietary protein and energy
intakes between the 65–75 vs. ≥75 year age groups, but these were significantly lower than
the <65 year age group (P <0.05).
Discussion
19

The main goals of nutrition management in ESKD are to maintain optimal nutritional status,
to preserve renal function and to achieve therapeutic targets. Findings of the current study
indicated that patients presented to the pre-dialysis assessment clinic with high prevalence of
suboptimal intake, nutrition abnormalities, malnutrition and parameters indicative of poor
nutritional health. The magnitude of these nutritional issues increased as renal function
deteriorated.
Our cohort was more advanced in age (65.7±13.6 years) and stages of CKD (mean GFR
~17.3±6.5) compared with the majority of previous studies (mean age of 50–55 years and
GFR of 20–55 mL/min/1.73m2) except in one study. In line with the findings in the
literature,7,

12, 13

nutritional status deteriorated with decreased renal function, in particular

once GFR levels fell below 20 mL/min/1.73m2. GFR levels at which symptoms emerged
varied enormously among individuals; the prevalence increased dramatically once GFR fell
below 15 mL/min/1.73m2. However, we also found 45% of patients with a GFR of >20
mL/min/1.73m2 experienced symptoms. Presence of symptoms was found in a patient with
a GFR as early as 41.6 mL/min/1.73m2, while some patients appeared fairly symptom- free
with a GFR below 10 mL/min/1.73m2.
Consistent with the literature,7, 8, 11-13, 15, 42 spontaneous DPI was lower with lower GFR, with
an average DPI of 1.18±0.42 g/kg IWB/d. The mean EI was comparable to that reported in
the literature,12-14, 42, 43 with a significant number of our patients consuming less energy than
recommended.20, 21, 41 Despite 76.2% of patients having an EI:REE ratio of less than 1.27 –
the Goldberg cut-off indicating possible underreporting as described by other researchers,34, 42
the suboptimal intake of our patients could largely be explained by the high prevalence of
malnutrition accompanied by unintentional weight loss, muscle wasting, high symptom
burden and physical inactivity. These observations were supported by a previous finding44
that lean body mass (LBM), bone mineral content and basal EE were lower in patients with
20

CKD (mean GFR 23.9±2.6 mL/min/1.73m2) compared with pair-matched controls. This
observation is further supported by a study that showed the commonly-used REE equations
were found to over-predict REE in CKD patients.45 Since no inflammatory marker, such as C
reactive protein (CRP), was measured, the inflammation state of our patients was not known
to interpret its effect on appetite, EI, REE, nutritional status, or its relationship with comorbidities. Unfortunately, from observation, many of our patients mistakenly perceived a
low EI was an acceptable effect of aging on lower food intake and physical inactivity, and
failed to recognise the presence of uraemic symptoms. Even more confusing was that in the
overweight/obese patients, a reduced intake could be a combination of intentional limiting of
EI to control weight and unintentional reduction due to uraemia. Malnutrition within the
overweight/obese group was prevalent at 30.5%; this observation could not be ignored as
being overweight and malnourished at the start of dialysis has been associated with high
mortality risk.6

An optimal level of protein in the diet of 0.75–1.00 g/kg IBW/d20 is recommended for this
population to control uraemia and symptoms;46,

47

most importantly, this must be

accompanied by an adequate intake of energy to maintain nitrogen balance.20, 40, 47 37.9% of
patients met the protein requirements but the majority (90.6%) did not meet energy
requirements. On the other hand, 43.7% of patients consumed protein above this level but EI
was poor. The undesirable combination of excess protein and low energy intakes has been
associated with adverse parameters in patients with advanced CKD.48, 49
It appears that the significant protein intake reduction occurred after GFR fell below
20 mL/min/1.73m2; this is in line with the findings that normalised protein catabolic rate
(nPCR) dropped when creatinine clearance (CrCl) fell below 25 mL/min8 and ended in a
dramatic decline when CrCl reached 15 mL/min.15 It is generally accepted that uraemia
causes spontaneous reduction or self-limiting of DPI; however in our cohort, despite a total
reduction of total energy or food intake, protein intake remained excessive in 61.2% of
21

patients, even those with reported reduced appetite and symptoms. This could partly be
explained by the high habitual protein intake of the average Australian adult as reported in
the national dietary survey, almost twice the RDI level of 0.75 g/kg/d.50,

51

Again, excess

protein intake has been associated with more rapid renal function deterioration and mortality
even in early CKD,52,

53

and increased uraemic toxins.46 Therefore, timely intervention to

optimise dietary intake is recommended.
Both the ADAT 5-point Likert scale appetite score and the combined “good appetite” vs.
“reduced appetite” score were found to be useful in ranking energy and protein intake, and
were useful in identifying adequate protein intake but not EI. A possible explanation is that
the average Australian consumes more protein than recommended discussed as above ,50, 51 so
a “reduced” protein intake in uraemic patients could still be adequate or in excess, but this is
not the same for total EI. These findings suggested subjective rating of appetite is insufficient
to reflect neither actual nor adequate dietary intake in a population with a gradual onset of
symptoms; thus structured interview and skilled diet history-taking should form an essential
part of nutritional assessment. To our knowledge, no previous study has analysed the PPVs of
appetite score and dietary intakes of energy and protein in patients with pre-dialysis ESKD.
Abnormal vitamin and mineral status, including retention and deficiency, are common in
patients with ESKD,54,

55

and are associated with increased morbidity and mortality.

Examples include low vitamin D levels and increased CVD risk,56-58 folic acid deficiency
relating to anaemia,59 elevated homocysteine and increased CVD risk,59 and iron deficiency
relating to resistance to recombinant erythropoietin (rHuEPO) to correct anaemia.60 Despite
the “mean” intake of many nutrients appearing satisfactory, a significant percentage of
patients did not meet the RDI of these nutrients (Table 4). The Lipid Lowering and Onset of
Renal Disease (LORD) trial42 baseline data suggested underreporting was responsible for the
low levels of nutrient intake. However, we consider our results close to the true intake as our
patients were more advanced in age (65.7±13.6 vs. 60.0±15.0 years) and in later stages of
22

CKD (GFR 17.3±6.5 vs. 40.3±19.4 mL/min/1.73m2) compared to those in the LORD study,
and also had high symptom burden.
Obesity and diabetes in CKD stages 2–5 are strongly associated with hypovitaminosis D;61
our cohort showed a high prevalence of obesity and suboptimal vitamin D intake, thus their
vitamin D status was likely to be poor. Consumption of the core foods such as fruit and
vegetables, the key contributors of antioxidants, phytochemicals, folates and dietary fibre,
were poor in a large number of our patients. Thus, these patients were likely to have elevated
levels of oxidative stress due to inadequate consumption of these nutrients and antioxidants.62
It was challenging to identify the duration and reason of such suboptimal intake, if these were
a result of uraemia and/or long-term poor eating habits similar to that reported in a national
health survey in the general population.63 An adequate fruit and vegetable consumption is
recommended as it has an alkali-inducing effect that is comparable to sodium bicarbonate in
decreasing markers of kidney injury.64, 65 A high dietary fibre intake has also been associated
with reduced risk of inflammation and mortality in patients with CKD.66,

67

Moreover, the

promising results of a prospective randomised study with a Mediterranean diet further
convince healthy eating to improve dyslipidaemia, markers of inflammation and lipid
peroxidation in stages 1–3 CKD patients.68 Data collection for vitamin and mineral
supplementation was incomplete for discussion. While some of these supplements are
necessary to correct certain clinical conditions in ESKD, they cannot replace optimal intake
of adequate energy, essential nutrients and food components from diet.
The majority of our patients were on a “free” diet prior to the initial clinic visit and presented
with parameters indicative of poor nutritional health. The possible cause was a combination
of advancing age, presence of uraemia and other symptoms, poor eating habits and selfinduced inappropriate diet regimens. It is a common stigma in the renal community that
dietary intervention in CKD implies restriction, which could cause malnutrition. Based on the
23

evidence from the literature and results of the current study, for CKD patients to stay on a
“free” diet or “free” from nutrition intervention is unlikely to achieve optimal nutrition;
worse, this may even cause a missing diagnosis of malnutrition and “self-induced” nutrition
abnormality in these patients. All these factors are known to have carry-on effects after
dialysis initiation and predict poor outcomes.

Nutrition requirements are indeed altered in ESKD and change over time. Although there is
much debate about the timing of initiation and type of nutrition intervention in ESKD,
before all the answers from high level of evidence are available, it appears logical to
incorporate “healthy eating” explicitly with renal nutrition guidelines and recommendations
to improve outcomes.

The main limitation of our study was the lack of data on inflammatory markers, such as CRP,
which is known to be closely associated with malnutrition and is a marker of CVD.9 It is
worth noting that CRP did not associate with low fat stores, which in fact reflects poor EI.69
Once again, this supports optimal EI being needed for optimal body composition. Other
limitations were the lack of measure of urinary protein appearance for estimating dietary
protein intake, as well as trace elements and antioxidants to verify the respective intakes as
these parameters were not routinely collected in our unit.
In summary, this pre-dialysis assessment clinic provided a platform to identify patients at
nutritional risk and to initiate nutrition intervention irrespective of future choice of dialysis or
conservative care programs. The results of this study also point to the needs for earlier
structured intervention to prevent and to manage the complex nutritional abnormalities found
in people with ESKD. Further studies are needed to gauge how to effectively implement the
complex and multifaceted aspects of nutrition management in ESKD.
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Conclusions
Patients presented to the current pre-dialysis assessment clinic with a high prevalence of
abnormal nutrition parameters, including under- (malnutrition) and over-nutrition (overweight
and obesity), compounded with a dietary intake of undesirable quality and quantity, either
voluntarily or involuntarily.

Practical Application
There is a high prevalence of nutritional abnormalities in pre-dialysis ESKD patients. The
pre-dialysis assessment clinic provides a platform to assess the nutritional status of ESKD
patients and to identify nutritional abnormalities for further intervention well before dialysis
is required.
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Table
Table 1. Demographic and clinical data of patients attending the pre-dialysis assessment
clinic
Parameters
Demographic
Age (year)
Age >65 year (%)
Age >75 year (%)
Gender (% male)
Race (% Caucasian)
Clinical and co-morbidities (%)
GFR (mL/min/1.73m2), n =207
CKD stages 3:4:5 (%), n =207
Smoking (% positive history), n =188
Coronary artery disease (%)
Diabetes mellitus (%)
Peripheral vascular disease (%)
Cerebral vascular disease (%)
Chronic lung disease (%)
Cause of ESKD
Chronic glomerulonephritis (%)
Diabetic nephropathy (%)
Renovascular disease/ hypertensive nephrosclerosis (%)
Adult polycystic kidney disease (%)
Analgesic nephropathy (%)
IgA nephropathy (%)
Reflux nephropathy/congenital abnormality (%)
Other or unknown causes (%)

n =210
65.7±13.6
64.3
28.1
60.5
85.7
17.3±6.5
5.3:56.5:3
8.2
45.7
34.8
35.2
17.1
16.2
10.5
16.7
24.3
21.4
5.2
4.8
9.5
6.2
11.9

Table 2. Nutritional characteristics of patients attending the pre-dialysis assessment
clinic
Nutritional parameters (n missing)
Anthropometry
Weight (kg)
Unintentional weight loss (presence of) in last 6
months (%)
Unintentional weight loss >5% in last 6 months (%)
Unintentional weight loss >5% in the past but
stabilised 6 months before clinic (%)
Body mass index (kg/m2)
BMI <23 kg/m2 (underweight)
BMI >26 kg/m2 (overweight & obese)
BMI >30 kg/m2 (obese)
MAMC (cm) (n =14)
MAMC % reference standard (%) (n =14)
MAMC 10% < reference standard (%) (n =14)
TSF (mm) (n =14)
TSF % reference standard (n =14)
Biochemistry
Serum creatinine (µmol/L) (n =1)
Serum albumin (g/L) (n =1)
Serum albumin below reference range (%) (n =1)
Malnutrition score
SGA A:B:C (%)
Malnourished (SGA B and C)
Malnourished + BMI >26 kg/m2
Malnourished + BMI >30 kg/m2

n = 210
76.1±17.0
29.1
8.1
3.8
28.1±5.7
17.1
62.4
31.4
24.9±3.7
97.8±14.1
28.6
16.1±8.6
108.5±55.5
389.3±121.7
34.4±6.0
37.3
%
59.5:36.7:3.8
40.5
19.0
9.5

Table 3. Appetite score and presence of symptoms
Appetite score: self-rated
(1) Very good
(2) Good
(3) Fair
(4) Poor
(5) Very poor
Combined:
(1)+(2) = Good appetite
(3)+(4)+(5) = Reduced appetite
Symptoms and behaviour
Presence of symptom (self-reported):
Nausea
Taste aversion
Total (reduced appetite and/or nausea and/or taste aversion)
Presence of symptom (self-reported + prompting by dietitian
during intake assessment)
Inappropriate self-imposed diet
Restrictive
In excess
Total

n =210 (%)
31.0
39.0
23.3
5.7
1.0
70.0
30.0
(%)
20.0
20.0
38.6
51.0
15.7
1.4
17.1

Table 4. Dietary Intake of patients attending the pre-dialysis assessment clinic
Energy/ nutrients/ foods (n
=206 for protein and
energy; n missing =2 for all
other parameters)
Energy (kcal/d)
Energy (kcal/kg IBW/d)
EI:REE
Protein (g/d)
Protein (g/kg IWB/d)
Protein (% energy)
Fat (% energy)
Carbohydrate (% energy)
Alcohol (% energy)
Monounsaturated fat (%
total fat)
Polyunsaturated fat (% total
fat)
Saturated fat (% total fat)
Thiamine, Vit. B1 (mg)
Riboflavin Vit. B2 (mg)
Niacin (mg)
Folate (µg)
Vitamin A (µg)
Vitamin C (mg)
Vitamin D (µg)
Vitamin E (mg)
Calcium (mg)
Phosphorous (mg)
Iodine (µg)
Iron (mg)
Magnesium (mg)
Phosphorous (mg)
Zinc (mg)
Dietary fibre (g/d)
Fruit (serves/d)
Vegetable (serves/d)
Fish (g/d)

Recommendation

Intake/day
mean±SD

Mean, %
recommended

30 for >60 yr*‡
35 for <60 yr*‡
>25†‡
>1.27
(Goldberg cutoff)
0.75–1.00*‡

1575.2±240
23.7±6.7

-

% below
recommendation
(or above if
indicated)
87.9

1.06±0.27

-

62.6
42.7

79.2±31.5
1.18±0.42

119.0±51.3

13.1 (61.2 >
recommendation)

15–20‡
~30‡
~50‡
~45‡

20.3±4.3
31.7±7.5
46.8±8.7
1.2±3.5
42.5±8.2

-

-

~45‡

22.9±8.8

-

-

<7§
1.1–1.2¶
0.9–1.6¶
14–16¶
400¶
700–900¶
45¶
5.0 (19–50yr)¶
10–15 (>50 yr)¶
7–10¶
1000–1300¶
1000 ¶
150¶
8¶
18 for female
(19–50yr) ¶
310–400¶
1000‡
8–14¶
25–30¶
2**
5**
30g§

34.7±10.3
1.6±1.2
1.7±1.4
44.7±26.6
395.1±356.3
890.4±553.7
100.3±72.6
3.1±2.5

137.6±99.7
132.5±112.9
280.8±120.1
98.8±89.1
108.4±67.0
222.6±160.4
31.8±33.6

36.8
41.2
1.0
67.6
52.9
22.1
100.0

8.2±4.0
543.4±277.5
1136.4±441.2
77.7±44.6
10.46±5.6

94.1±45.5
47.8±27.5
114.0±43.5
52.6±29.7
120.1±47.9

61.8
96.6
40.7
94.6
36.3

247.8±83.8
1129.2±458.3
11.2±9.0
21.4±8.4
2.0±1.5
2.8±1.5
33.6±52.5

65.2±20.5
116.8±78.6
90.6±39.3
76.0±29.3
101.7±70.0
54.75±29.7
110.7±175.0

94.1
41.6
64.2
80.4
41.3
89.2
60.8

* K/DOQI guidelines40
† PEW classification21
‡ Evidence-based practice guidelines for the nutritional management of chronic kidney disease20
§ American Heart Association38
¶
NH&MRC nutrient reference values for the general Australian population 41
** Go for 2 fruit & 5 vegetables™ campaign37

Table 5. Demographic, clinical and nutritional parameters in different GFR ranges
GFR (mL/min/1.73m2)
<10
10–15
15–20
>20
P value
n (% of 209 total)
20 (9.5%) 62 (29.7%) 69 (33.0%)
58 (27.8%)
(n missing)
8.4±1.4
12.5±1.4
17.4±1.4
25.1±5.7
n/a
Mean GFR
(mL/min/1.73m2)
Age (year)
71.2±13.9
70.8±12.4
66.9±11.8
57.4±13.3*†‡
<0.0001
†
Serum creatinine
604.3±152. 437.6±79*
361.2±72*
297.5±71.0*†‡ <0.0001
(µmol/L)
4
s-alb (g/L)
30.4±6.6
34.9±6.2*
34.0±6.4
35.7±4.4*
0.006
s-alb below reference
65
38.7
39.1
24.1
0.01
range (%)
BMI (kg/m2)
22.7±2.9
26.1±4.3
29.0±4.9*†
30.8±6.7*†
<0.0001
MAMC (% of standard)
87.7±8.4
95.1±13.2
99.4±13.5*
103.0±15.4*† <0.0001
(n =14)
TSF (% of standard)
68.0±24.9
95.0±47.1
118.0±53.5*
126.4±64.9*† <0.0001
(n =14)
Malnourished, SGA score
<0.0001
80.0
48.4
29.0
31.0
B and C (%)
Presence of symptom (%)
75.0
56.5
45.0
43.1
0.05
Energy (kcal/kg IBW/d)
21.6±8.5
23.0±6.0
23.64±6.6
25.10±6.8
0.18
(n =15)
Protein (g/kg IBW/d)
0.95±0.37
1.08±0.34
1.24±0.46*
1.31±0.44*†
0.001
(n =15)
Abbreviation: GFR = glomerular filtration rate; s-alb = serum albumin; BMI = body mass index;
MAMC = mid-arm muscle circumference; TSF = triceps skinfold; SGA = subjective global
assessment
For the continuous variables:
* P <0.05 as compared with the GFR <10 mL/min/1.73m2 group
† P <0.05 as compared with the GFR =10–15 mL/min/1.73m2 group
‡ P <0.05 as compared with the GFR =15–20 mL/min/1.73m2 group

Table 6. Demographic, clinical and nutritional parameters across different age
categories
Age group (year)
n (% of 210 total)
(n missing)
Age (year)
GFR (mL/min/1.73m2)
Serum creatinine (µmol/L)

<65
75 (35.6)

65–75
77 (36.7)

>75
58 (26.7)

P value

50.6±10.4
20.3±6.8
400.0±146.
0
35.4±6.9
29.7
28.4±6.9
100.6±16.2

70.3±3.0*
16.7±4.8*
376.2±0.094

79.1±3.0*†
13.5±4.9*†
394.2±120.
6
35.7±3.4
46.4
26.0±5.7*†
93.5±12.2*

<0.0001
<0.0001
0.48

s-alb (g/L)
36.0±5.5
0.85
s-alb < reference range (%)
37.7
0.14
2
BMI (kg/m )
29.3±4.9
0.003
MAMC (% of standard)
98.7±12.7
0.02
(n =14)
TSF (% of standard)
108.7±55.4 117.7±54.4
95.8±55.6
0.08
(n =14)
Malnourished, SGA score B
<0.0001
21.3
48.1
55.2
or C (%)
Presence of symptom (%)
32.0
66.2
55.2
<0.0001
Energy (kcal/kg IBW/d)
27.9±6.8
21.2±5.9*
21.8±4.9*
<0.0001
(n =4)
Protein (g/kg IBW/d)
1.44±0.44
1.07±0.39*
1.01±0.43* <0.0001
(n =4)
Abbreviation: GFR = glomerular filtration rate; s-alb = serum albumin; BMI = body mass
index; MAMC = mid-arm muscle circumference; TSF = triceps skinfold; SGA = subjective
global assessment
For the continuous variables:
* P <0.05 as compared with the age <65 year group
† P <0.05 as compared with the age =65–75 year group

Figures
Figure 1. Energy intake and glomerular filtration rate
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Figure 2. Protein intake and glomerular filtration rate
3.50

Protein (g/kg IBW/d)

r =0.29, P <0.0001
2.50
2.00
1.50
1.00
0.50
0.00
0.0

10.0

20.0

30.0

40.0

GFR mL/min/1.73m2

▲ Denotes patients with self-imposed inappropriate intake
--- Denotes 0.75g/kg IBW/d to 1.0g/kg IBW/d of protein

50.0

60.0

Figure 3. Self-rated appetite score (5 points) and energy intake
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Figure 4. Self rated appetite score (5 points) and protein intake

P <0.006

--- Denotes 0.75g/kg IBW/d to 1.0g/kg IBW/d of protein

